ALFA Filings
Every announcement, straight from the exchange
Every Shilpa Medicare business update announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Shilpa Medicare Limited’s Unit 4 in Jadcherla received GMP certification from AGES, Austria, following a successful inspection. This milestone enables operations for European and global markets.
Shilpa Medicare reported a USFDA surveillance inspection at its Unit VII Analytical Services Division. The inspection resulted in one procedural observation with no material impact on operations.
Shilpa Biologicals has entered a co‑development and supply agreement with Finland's Orion for a nivolumab biosimilar. The partnership expands Shilpa's European market footprint.
Shilpa Medicare's Bengaluru facility concluded a USFDA inspection with five procedural observations. The company expects no material impact on operations and will respond within timelines.